
<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#">
  
<!-- Mirrored from investors.scholarrock.com/node/9506/html by HTTrack Website Copier/3.x [XR&CO'2014], Sat, 21 Dec 2024 12:08:04 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=UTF-8" /><!-- /Added by HTTrack -->
<head>
    <title>SEC Filing - Scholar Rock, Inc.</title>
    <meta name="robots" content="noindex">
    <link rel="stylesheet" media="all" href="../../sites/g/files/knoqqb56236/files/css/css_-Ogun-b4Vwq8nD6qwBoEYuBhEF_0grnAaUrH4akFvLUcd37.css?delta=0&amp;language=en&amp;theme=nir_pid2662&amp;include=eJyNjEEKgDAMBD8k9UkhTQMGSiJNRfp7ayuePHjK7jAblQIRnVdnAq8tsy_a2cnRpTKoVSH29YOF5w5__LiDkOlEqJhbN-b4bQGTRYaMh9L2Q9yLpQuf0kIl" />

    
    <!-- IrwinIQ Tag Manager --> <script> (function(w,d){ var _mtm = w._mtm = w._mtm || []; _mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'}); var g=d.createElement('script'), s=d.getElementsByTagName('script')[0]; g.async=true; g.src='../../../analytics.imirwin.com/js/container_XFyWYf0m.js'; s.parentNode.insertBefore(g,s); })(window, document); </script> <!-- End IrwinIQ Tag Manager -->

<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-WTGMF33');</script>
<!-- End Google Tag Manager -->

<!-- Google Tag Manager (noscript) -->
<noscript><iframe src="../../../www.googletagmanager.com/nsca0c.html?id=GTM-WTGMF33"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->
  </head>
  <body class="body-sidebars-first nir-node nir-node--type-nir-sec-filing nir-node--9506 page-template-default page page-parent wp-custom-logo wp-embed-responsive full-width-content genesis-breadcrumbs-visible genesis-singular-image-hidden genesis-footer-widgets-visible top-parent-investors-media investors-media has-no-blocks elementor-default elementor-page cbp-spmenu-push cookies-set cookies-accepted body_classes" id="body" cz-shortcut-listen="true">
      <div class="region region-content">
    <div id="block-nir-pid2662-websitenoticeblock" class="block--website-notice-block block--website-notice-block--9506 block--content--website-notice-block block--content--website-notice-block--9506 block--24a64b1d-13aa-4b20-8029-2df59f99a96c block--24a64b1d-13aa-4b20-8029-2df59f99a96c--9506 block block-nir-website-notices block-website-notice-block">
  
    
      
  </div>
<div data-drupal-messages-fallback class="hidden"></div>

<div id="block-nir-pid2662-content" class="block--system-main-block block--system-main-block--9506 block--content--system-main-block block--content--system-main-block--9506 block--c4d2f333-a7f8-46c4-afc3-3e36992b73c0 block--c4d2f333-a7f8-46c4-afc3-3e36992b73c0--9506 block block-system block-system-main-block">
  
    
      <div class="nir-sec-header"><div class="logo"><img src="../../sites/g/files/knoqqb56236/files/Logo.png" alt="Scholar Rock, Inc." />
</div><div class="sec-docs">View:  <div class="file-link">
  <span class="file file--mime-application-rtf file--general"> <a href="../../static-files/0001415889-23-010190.rtf%3b%20filename_%3dUTF-8%27%270001415889-23-010190.rtf" type="application/rtf" title="0001415889-23-010190.rtf">Download DOC</a></span><span class="filesize"> </span>
</div>
  <div class="file-link">
  <span class="file file--mime-application-pdf file--application-pdf"> <a href="../../static-files/0001415889-23-010190.pdf%3b%20filename_%3dUTF-8%27%270001415889-23-010190.pdf" type="application/pdf" title="0001415889-23-010190.pdf">Download PDF</a></span><span class="filesize"> </span>
</div>
  <div class="file-link">
  <span class="file file--mime-application-vnd-ms-excel file--x-office-spreadsheet"> <a href="../../static-files/0001415889-23-010190.xls%3b%20filename_%3dUTF-8%27%270001415889-23-010190.xls" type="application/vnd.ms-excel" title="0001415889-23-010190.xls">Download XLS</a></span><span class="filesize"> </span>
</div>
</div></div>
    <!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>SEC FORM 
            3</title>
<style type="text/css">
              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; 
              		font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}
              body {background: white;}
      </style>
</head>
<body>SEC Form 3 
   <table width="100%" border="0" cellspacing="0" cellpadding="4"><tr>
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 3</td>
<td rowspan="1" width="60%" valign="middle" align="center">
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
</td>
<td rowspan="1" width="20%" valign="top" align="center">&nbsp;<table width="100%" border="1" summary="OMB Approval Status Box">
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
<tr>
<td class="SmallFormText" colspan="3">OMB Number:</td>
<td class="SmallFormTextR">3235-0104</td>
</tr>
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
<tr>
<td class="SmallFormText" colspan="3">hours per response:</td>
<td class="SmallFormTextR">0.5</td>
</tr>
</table></td></tr>
</table></td>
</tr></table>
<table width="100%" border="1" cellspacing="0" cellpadding="4">
<tr>
<td rowspan="3" width="30%" valign="top">
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="../../../www.sec.gov/cgi-bin/browse-edgar2e6c?action=getcompany&amp;CIK=0001980298">Qatanani Mo</a></td></tr></table>
<hr width="98%">
<table border="0" width="100%"><tr>
<td width="33%" class="MedSmallFormText">(Last)</td>
<td width="33%" class="MedSmallFormText">(First)</td>
<td width="33%" class="MedSmallFormText">(Middle)</td>
</tr></table>
<table border="0" width="100%">
<tr><td><span class="FormData">301 BINNEY STREET</span></td></tr>
<tr><td><span class="FormData"></span></td></tr>
</table>
<hr width="98%">
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
<td width="33%"><span class="FormData">CAMBRIDGE</span></td>
<td width="33%"><span class="FormData">MA</span></td>
<td width="33%"><span class="FormData">02142</span></td>
</tr></table>
<hr width="98%">
<table border="0" width="100%"><tr>
<td width="33%" class="MedSmallFormText">(City)</td>
<td width="33%" class="MedSmallFormText">(State)</td>
<td width="33%" class="MedSmallFormText">(Zip)</td>
</tr></table>
</td>
<td rowspan="3" width="15%" valign="top">
<span class="MedSmallFormText">2. Date of Event Requiring Statement
         (Month/Day/Year)</span><br><span class="FormData">06/21/2023</span>
</td>
<td valign="top" colspan="2">
<span class="MedSmallFormText">3. Issuer Name <b>and</b> Ticker or Trading Symbol
      </span><br><a href="../../../www.sec.gov/cgi-bin/browse-edgar39a0?action=getcompany&amp;CIK=0001727196">Scholar Rock Holding Corp</a>
     [ <span class="FormData">SRRK</span> ]
   </td>
</tr>
<tr>
<td rowspan="2" width="30%" valign="top">
<span class="MedSmallFormText">4. Relationship of Reporting Person(s) to Issuer
      </span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
<tr>
<td width="15%" align="center"></td>
<td width="35%" class="MedSmallFormText">Director</td>
<td width="15%" align="center"></td>
<td width="35%" class="MedSmallFormText">10% Owner</td>
</tr>
<tr>
<td align="center"><span class="FormData">X</span></td>
<td class="MedSmallFormText">Officer (give title below)</td>
<td align="center"></td>
<td class="MedSmallFormText">Other (specify below)</td>
</tr>
<tr><td colspan="4" align="center">
<span class="FormData">SVP and Head of Research</span><span class="FormData"></span>
</td></tr>
</table>
</td>
<td valign="top">
<span class="MedSmallFormText">5. If Amendment, Date of Original Filed
         (Month/Day/Year)</span><br>
</td>
</tr>
<tr><td valign="top">
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
      </span><table border="0" width="100%">
<tr>
<td width="15%" align="center"><span class="FormData">X</span></td>
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
</tr>
<tr>
<td width="15%" align="center"></td>
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
</tr>
</table>
</td></tr>
</table>
<table width="100%" border="1" cellspacing="0" cellpadding="4">
<thead>
<tr><th width="100%" valign="top" colspan="4" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Beneficially Owned</b></th></tr>
<tr>
<th width="44%" valign="top" align="left" class="MedSmallFormText">1. Title of Security (Instr. 
      4)
   </th>
<th width="19%" valign="top" align="left" class="MedSmallFormText">2. 
      Amount of Securities Beneficially Owned (Instr. 
      4)
   </th>
<th width="11%" valign="top" align="left" class="MedSmallFormText">3. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th>
<th width="26%" valign="top" align="left" class="MedSmallFormText">4. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><span class="FormData">Common Stock</span></td>
<td align="center">
<span class="FormData">21,000</span><span class="FootnoteData"><sup>(1)</sup></span>
</td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"><span class="FormData"></span></td>
</tr>
<tr>
<td align="left"><span class="FormData">Common Stock</span></td>
<td align="center">
<span class="FormData">22,500</span><span class="FootnoteData"><sup>(2)</sup></span>
</td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"><span class="FormData"></span></td>
</tr>
<tr>
<td align="left"><span class="FormData">Common Stock</span></td>
<td align="center">
<span class="FormData">22,425</span><span class="FootnoteData"><sup>(3)</sup></span>
</td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"><span class="FormData"></span></td>
</tr>
<tr>
<td align="left"><span class="FormData">Common Stock</span></td>
<td align="center">
<span class="FormData">5,125</span><span class="FootnoteData"><sup>(4)</sup></span>
</td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"><span class="FormData"></span></td>
</tr>
<tr>
<td align="left"><span class="FormData">Common Stock</span></td>
<td align="center">
<span class="FormData">33,750</span><span class="FootnoteData"><sup>(5)</sup></span>
</td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"><span class="FormData"></span></td>
</tr>
</tbody>
</table>
<table width="100%" border="1" cellspacing="0" cellpadding="4">
<thead>
<tr><th width="100%" valign="top" colspan="8" align="center" class="FormTextC">
<b>Table II - Derivative Securities Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
</th></tr>
<tr>
<th width="35%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Derivative Security (Instr. 
      4)
   </th>
<th width="9%" valign="top" colspan="2" align="left" class="MedSmallFormText">2. Date Exercisable and Expiration Date 
      (Month/Day/Year)</th>
<th width="26%" valign="top" colspan="2" align="left" class="MedSmallFormText">3. Title and Amount of Securities Underlying Derivative Security (Instr. 
      4)
   </th>
<th width="7%" valign="top" rowspan="2" align="left" class="MedSmallFormText">4. Conversion or Exercise Price of Derivative Security
   </th>
<th width="8%" valign="top" rowspan="2" align="left" class="MedSmallFormText">5. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th>
<th width="15%" valign="top" rowspan="2" align="left" class="MedSmallFormText">6. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th>
</tr>
<tr>
<th width="4%" valign="bottom" align="center" class="MedSmallFormText">Date Exercisable</th>
<th width="5%" valign="bottom" align="center" class="MedSmallFormText">Expiration Date</th>
<th width="20%" valign="bottom" align="center" class="MedSmallFormText">Title</th>
<th width="6%" valign="bottom" align="center" class="MedSmallFormText">Amount or Number of Shares</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><span class="FormData">Stock Option (Right to Buy)</span></td>
<td align="center">
<span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(6)</sup></span>
</td>
<td align="center"><span class="SmallFormData">10/26/2031</span></td>
<td align="center"><span class="FormData">Common Stock</span></td>
<td align="center"><span class="FormData">70,000</span></td>
<td align="center"><span class="FormData">26.05</span></td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"><span class="FormData"></span></td>
</tr>
<tr>
<td align="left"><span class="FormData">Stock Option (Right to Buy)</span></td>
<td align="center">
<span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(7)</sup></span>
</td>
<td align="center"><span class="SmallFormData">02/14/2032</span></td>
<td align="center"><span class="FormData">Common Stock</span></td>
<td align="center"><span class="FormData">22,500</span></td>
<td align="center"><span class="FormData">18.08</span></td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"><span class="FormData"></span></td>
</tr>
<tr>
<td align="left"><span class="FormData">Stock Option (Right to Buy)</span></td>
<td align="center">
<span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(8)</sup></span>
</td>
<td align="center"><span class="SmallFormData">06/16/2032</span></td>
<td align="center"><span class="FormData">Common Stock</span></td>
<td align="center"><span class="FormData">22,425</span></td>
<td align="center"><span class="FormData">4.86</span></td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"><span class="FormData"></span></td>
</tr>
<tr>
<td align="left"><span class="FormData">Stock Option (Right to Buy)</span></td>
<td align="center">
<span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(9)</sup></span>
</td>
<td align="center"><span class="SmallFormData">10/10/2032</span></td>
<td align="center"><span class="FormData">Common Stock</span></td>
<td align="center"><span class="FormData">5,125</span></td>
<td align="center"><span class="FormData">7.62</span></td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"><span class="FormData"></span></td>
</tr>
<tr>
<td align="left"><span class="FormData">Stock Option (Right to Buy)</span></td>
<td align="center">
<span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(10)</sup></span>
</td>
<td align="center"><span class="SmallFormData">02/13/2033</span></td>
<td align="center"><span class="FormData">Common Stock</span></td>
<td align="center"><span class="FormData">45,000</span></td>
<td align="center"><span class="FormData">10</span></td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"><span class="FormData"></span></td>
</tr>
</tbody>
</table>
<table border="0" width="100%">
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
<tr><td class="FootnoteData">1. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment vesting on September 15, 2022 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date.</td></tr>
<tr><td class="FootnoteData">2. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment vesting on January 15, 2023 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date.</td></tr>
<tr><td class="FootnoteData">3. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in three annual installments over three years, with the first annual installment vesting on June 15, 2023 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date.</td></tr>
<tr><td class="FootnoteData">4. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment vesting on September 15, 2023 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date.</td></tr>
<tr><td class="FootnoteData">5. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment vesting on February 15, 2024 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date.</td></tr>
<tr><td class="FootnoteData">6. 43,750 shares remain unvested under this stock option. The first vesting event occurred on September 30, 2022 and the remainder will vest in twelve quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date.</td></tr>
<tr><td class="FootnoteData">7. 15,469 shares remain unvested under this stock option. The first vesting event occurred on April 1, 2022 and the remainder will vest in fifteen quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date.</td></tr>
<tr><td class="FootnoteData">8. 14,950 shares remain unvested under this stock option. The first vesting event occurred on September 16, 2022 and the remainder will vest in eleven quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date.</td></tr>
<tr><td class="FootnoteData">9. 4,485 shares remain unvested under this stock option. The first vesting event occurred on January 5, 2023 and the remainder will vest in fifteen quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date.</td></tr>
<tr><td class="FootnoteData">10. 42,188 shares remain unvested under this stock option. The first vesting event occurred on April 1, 2023 and the remainder will vest in fifteen quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date.</td></tr>
</table>
<table width="100%" border="0">
<tr>
<td width="60%"></td>
<td width="20%"><u><span class="FormData">/s/ Junlin Ho, Attorney-in-Fact for Mo Qatanani</span></u></td>
<td width="20%"><u><span class="FormData">06/22/2023</span></u></td>
</tr>
<tr>
<td></td>
<td class="MedSmallFormText">** Signature of Reporting Person</td>
<td class="MedSmallFormText">Date</td>
</tr>
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person, 
                  <i>see</i>

                  Instruction 
                  5

                  (b)(v).</td></tr>
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations 
                  <i>See</i>

                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, 
                  <i>see</i>

                  Instruction 6 for procedure.</td></tr>
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
</table>
</body>

<!-- Mirrored from investors.scholarrock.com/node/9506/html by HTTrack Website Copier/3.x [XR&CO'2014], Sat, 21 Dec 2024 12:08:04 GMT -->
</html>
<div><a name="ex24-06222023_100607.htm"></a></div><!DOCTYPE html PUBLIC "-//IETF//DTD HTML//EN">
<html><head><title>ex24-06222023_100607.htm</title></head><body style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<p style="margin:0px; font-size:11pt" align="right">Exhibit 24</p>
<p style="margin:0px" align="right"><br></p>
<p style="margin:0px; font-size:11pt">LIMITED POWER OF ATTORNEY</p>
<p style="margin:0px"><br></p>
<p style="margin:0px; font-size:11pt">The undersigned hereby constitutes and appoints each of Sarah Ashfaq and Junlin Ho, and any designee thereof, signing singly, and with full power of substitution, the undersigned<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s true and lawful attorney-in-fact to:</p>
<p style="margin:0px"><br></p>
<p style="margin:0px; font-size:11pt">(1)<font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font>execute for and on behalf of the undersigned, in the undersigned<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s capacity as an officer and/or director of Scholar Rock Holding Corporation (the <font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font>Company<font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>), from time to time the following U.S. Securities and Exchange Commission (<font style="font-family:Arial Unicode MS,Times New Roman">&ldquo;</font>SEC<font style="font-family:Arial Unicode MS,Times New Roman">&rdquo;</font>) forms: (i) Form ID, including any attached documents, to effect the assignment of codes to the undersigned to be used in the transmission of information to the SEC using the EDGAR System; (ii) Form 3, Initial Statement of Beneficial Ownership of Securities, including any attached documents; (iii) Form 4, Statement of Changes in Beneficial Ownership of Securities, including any attached documents; (iv) Form 5, Annual Statement of Beneficial Ownership of Securities in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder, including any attached documents; (v) Schedule 13D, (vi) Schedule 13G and (vii) amendments of each thereof, in accordance with the Securities Exchange Act of 1934, as amended, and the rules thereunder, including any attached documents;</p>
<p style="margin:0px; font-size:11pt">(2)<font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font>do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, Schedule 13D, Schedule 13G or any amendment(s) thereto, and timely file such form(s) with the SEC and any securities exchange, national association or similar authority; and</p>
<p style="margin:0px; font-size:11pt">(3)<font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font><font style="font-family:Arial Unicode MS,Times New Roman">&#8239;</font>take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s discretion.</p>
<p style="margin:0px; font-size:11pt">The undersigned hereby grants to each such attorney-in-fact, acting singly, full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s responsibilities to comply with Section 16 or Regulation 13D-G of the Securities Exchange Act of 1934, as amended. The undersigned hereby agrees to indemnify the attorney-in-fact and the Company from and against any demand, damage, loss, cost or expense arising from any false or misleading information provided by the undersigned to the attorney-in-fact.</p>
<p style="margin:0px; font-size:11pt">This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file such forms with respect to the undersigned<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. This Power of Attorney supersedes any prior power of attorney in connection with the undersigned<font style="font-family:Arial Unicode MS,Times New Roman">&rsquo;</font>s capacity as an officer and/or director of the Company. This Power of Attorney shall expire as to any individual attorney-in-fact if such attorney-in-fact ceases to be an executive officer of the Company.</p>
<p style="margin:0px"><br></p>
<p style="margin:0px; font-size:11pt">IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of June 21, 2023.</p>
<p style="margin:0px"><br></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0" width="100%" align="center"><tr style="font-size:0"><td width="166.667"></td><td width="145.333"></td><td width="21.333"></td><td width="290.667"></td></tr><tr><td style="margin-top:0px; padding-left:4px; padding-top:0px; padding-right:4px; padding-bottom:0px" valign="top" width="166.667"><p style="margin:0px"><br></p>
</td><td style="margin-top:0px; padding-left:4px; padding-top:0px; padding-right:4px; padding-bottom:0px; border-bottom:1.333px solid #000000" valign="top" width="166.667" colspan="2"><p style="margin:0px; font-size:11pt">/s/ Mo Qatanani</p>
</td><td style="margin-top:0px; padding-left:4px; padding-top:0px; padding-right:4px; padding-bottom:0px; border-bottom:1.333px solid #000000" valign="top" width="290.6" colspan="2"><p style="margin:0px; padding-left:4px; padding-right:4px; font-size:11pt">&nbsp;</p></td></tr><tr><td style="margin-top:0px; padding-left:4px; padding-top:0px; padding-right:4px; padding-bottom:0px" valign="top" width="312" colspan="2"><p style="margin:0px"><br></p>
</td><td style="margin-top:0px; padding-left:4px; padding-top:0px; padding-right:4px; padding-bottom:0px" valign="top" width="312" colspan="2"><p style="margin:0px; font-size:11pt">By: Mo Qatanani </p>
</td></tr></table><p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<div style="width:268.8px">
<p style="margin:0px; width:268.8px; font-size:8pt">ACTIVE/123574557.1 </p>
<p style="margin:0px"><br></p>
</div>
<p style="margin:0px"><br></p>
</body></html>


  </div>

  </div>

          <script type="text/javascript">var s_CCSWebHostingAccount = "trcgscholarrock";</script>
        <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/9506\/html","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","themeUrl":"sites\/g\/files\/knoqqb56236\/themes\/site\/nir_pid2662"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"user":{"uid":0,"permissionsHash":"4506f7b957b4baf2488ee006e9b884f3b49293f46cfb6e03ffbb15fedba12da4"}}</script>
<script src="../../sites/g/files/knoqqb56236/files/js/js_D31miEwayYNfIODJWy2ump8i_gwklTzvOKq4eFgXiKw4996.js?scope=footer&amp;delta=0&amp;language=en&amp;theme=nir_pid2662&amp;include=eJyNjEEKgDAMBD8k9UkhTQMGSiJNRfp7ayuePHjK7jAblQIRnVdnAq8tsy_a2cnRpTKoVSH29YOF5w5__LiDkOlEqJhbN-b4bQGTRYaMh9L2Q9yLpQuf0kIl"></script>
<script src="../../../assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js" crossorigin="anonymous" async integrity="sha384-9QSqHMB+yiy/V4i+d2Au+ydEWbBz4E9DqsE+oYKOnL+kj4XAZGYZxabd0P3OGHkf"></script>

  </body>
</html>
